ImprimisRx NJ recalls

ImprimisRx NJ has 4 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 16 Sep 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls4since 2019

Last 12 months1reported

Class I00% of total

Ongoing1latest 16 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 1 0

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why imprimisrx nj is recalled

Potency & Assay4100%

Product types

Eye Drops4100%

By year

2026125%
2022125%
2019250%

Ongoing imprimisrx nj recalls

1 active

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS III	Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic recalled	ImprimisRx NJ	Potency & Assay	Nationwide

All imprimisrx nj recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS III	Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic recalled	ImprimisRx NJ	Potency & Assay	Nationwide
23 Nov 2022Drug	CLASS II	Timolol-Latanoprost (0.5/0.005%) ophthalmic drops recalled	ImprimisRx NJ	Potency & Assay	Nationwide
7 Aug 2019Drug	CLASS II	Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops recalled	ImprimisRx NJ	Potency & Assay	Nationwide
7 Aug 2019Drug	CLASS II	Timolol- Dorzolamide- Latanoprost recalled by ImprimisRx NJ	ImprimisRx NJ	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.